Indian Generic Drug Maker Targets Sad Americans

January 3, 2007 · Filed Under General 

by H.S. Ayoub
BioHealth Investor

I read a very well written article penned recently by Nature staff reporter Erika Check for Wired Magazine.

Ms.Check profiles a popular nationalist in India by the name of Khwaja Abdul Hamied, a chemist who founded The Chemical, Industrial, & Pharmaceutical Laboratories, or CIPLA for short.

Cipla has become a very successful company in a developing region of the world through the production and marketing of generic drugs. Its success however is not entirely a direct effect of its legal business activities. Its current leader, Dr.Yusuf Hamied, the enthusiastically nationalistic son of the founder, is aggressively pirating patented formulations from big Western pharmas and selling them in developing countries whose patent protection laws do not match those of developed nations.

Well, ‘pirating’ is what big pharma labels Cipla’s actions, but Dr.Hamied thinks otherwise. His savvy public outcries for cheaper medicine for the poor and his constant condemnation of the richer pharmaceuticals and their nations have garnered him a sort of cult following in India and surrounding poor nations.

Some of the drugs produced by Cipla include a version of Pfizer’s (PFE) Viagra called Erecto, and a supply of oseltamivir which is the active ingredient of Roche’s (ROG.L) Tamiflu.

Cipla is marketing to nations whose people constantly criticize the U.S. and other rich Western nations. More importantly, from a business perspective, developing markets are also gaining financial strength, especially those of India and Asian nations. Cipla has done well utilizing these trends in its promotional efforts.

But that was then, when India’s patent laws were almost non-existent, and this is now, as India has recently changed its legislation. Cipla now is forced to develop and market generic drugs legally, and will do so in Western nations, including the U.S.

One of Cipla’s first targets in the U.S. will be Pfizer’s anti-depressant blockbuster Zoloft (sertraline). Cipla is already developing a large inventory of sertraline in one of its Indian manufacturing facilities.

But can Dr.Hamied have the same success playing by the rules? As mentioned before, Cipla strived on rallying the nationalistic fervor of poorer regions. It will be interesting to see how the company will do promoting its generics to Americans legally.

Already, Dr.Hamied has began his rally cries by criticizing the existing system in the U.S. for charging Americans too much for medication.

Could his initial U.S. target of depressed Americans be a well thought out strategy?

__________

Related articles:
- Gilead to License Generic Viread to Companies in India
- Offshoring of Biotech Research to China

Comments

3 Responses to “Indian Generic Drug Maker Targets Sad Americans”

  1. Medifills on January 23rd, 2010 12:21 am

    Very valuable information your provided about obesity. Many of my questions were answered.

  2. adhellefT on March 2nd, 2010 11:36 pm

    The response to national disaster is noble but it’s a real shame that so many people take advantage of the sad situations.

    I mean everytime there is an earthquake, a flood, an oil spill – there’s always a group of heartless people who rip off tax payers.

    This is in response to reading that 4 of Oprah Winfreys “angels” got busted ripping off the system. Shame on them!
    http://www.cbsnews.com/blogs/2009/08/19/crimesider/entry5251471.shtml

  3. Sleepearf on March 6th, 2010 11:33 am

    Green Enegry Program

    Israel Telemarketing services

    Cool
    My 1st Post To this location.
    looking to meet new people

    After years of research and development, Ozzie and his staff discovered how to safely use 100-year-old technology – technology that had been suppressed and misunderstood – to create hydrogen from water. Starting in a small apartment in Studio City, CA, Water4Gas began demonstrating this powerful technology to local residents and friends. The business developed into a small manufacturer of home-made Water4Gas conversion systems, but demand became so heavy that Ozzie realized he must do more to expand this technology. He decided to phase out of product production in order to teach the world of his findings.

    As demand grew, so did the need for this technology. With fuel prices topping an astounding $5 per gallon in the US in mid 2008, Water4Gas took their message to the media with national radio shows, TV news reports and demonstration events occurring in many cities all over the country.

    •…showed a potential for very low pollutant emissions with increased energy efficiency. 81]

    The Society of Automotive Engineers (Troy, Michigan)
    If you were under the impression that American automotive engineers (Detroit) are unaware of the benefits of hydrogen-on-demand, here’s a wake-up pile of evidence; just a few of the many references from their official publications of the last 35 years!!! Proof that they KNOW all about it but say noting to the public:

    ————————————————————————————————————————————-

Leave a Reply




    Subscribe to BioHealth Investor BioHealth Investor RSS Feed